Millimeter polarisation of the protoplanetary nebula OH 231.8+4.2: A follow-up study with CARMA

In order to investigate the characteristics and influence of the magnetic field in evolved stars, we performed a follow-up investigation of our previous submillimeter analysis of the proto-planetary nebula (PPN) OH 231.8+4.2 (Sabin et al. 2014), this time at 1.3mm with the CARMA facility in polarisation mode for the purpose of a multi-scale analysis. OH 231.8+4.2 was observed at ~2.5" resolution and we detected polarised emission above the 3-sigma threshold (with a mean polarisation fraction of 3.5 %). The polarisation map indicates an overall organised magnetic field within the nebula. The main finding in this paper is the presence of a structure mostly compatible with an ordered toroidal component that is aligned with the PPN's dark lane. We also present some alternative magnetic field configuration to explain the structure observed. These data complete our previous SMA submillimeter data for a better investigation and understanding of the magnetic field structure in OH 231.8+4.2.Comment: 7 pages, 5 figures, 2 tables. Accepted for publication in MNRA

Establishment of the Minimum Biological Capacity for Nitrogen Excretion in Pigs

To determine the minimum biological capacity for nitrogen (N) excretion for pigs, dietary regimens were created and fed that were designed to eliminate fecal excretion of undigested feed N, minimize endogenous N secretions and minimize intakes of nitrogenous compounds (amino acids) above those of the pigs biological needs. Excretion of undigested fecal N was eliminated by feeding ingredients containing highly digestible (≈100%) sources of nitrogen and by eliminating compounds that bind N. Endogenous secretions were minimized by eliminating antinutritional factors from the diet and by minimizing enteric bacterial populations. Intakes of amino acids above the animal\u27s needs were minimized by providing a pattern of amino acids that closely matched that needed by the pig. Furthermore, dietary amino acids were provided to the pigs in amounts above, at, and below their biological needs based on the amounts of urea N excreted in the urine and the amounts of N accrued in the body. From two-slope breakpoint analysis, apparent digestible N intake resulting in maximum N retention (2.58g⋅kg-1BW.75⋅d-1) was determined to be 3.66g⋅kg-1BW.75⋅d-1. When daily apparent digestible nitrogen intakes were below the pigs\u27 determined need, the amount of digestible N (mg⋅kg-1BW.75⋅d-1) lost for body maintenance processes was estimated as .239 in urine and .080 in feces. The amount lost in urine as unusable for body N accretion was .206 g⋅kg-1BW.75⋅d-1 of each gram of digestible N consumed above body maintenance needs. When daily apparent digestible N intakes were above the pigs determined need, .900 g of each gram of additional N consumed above that needed for body N accretion was excreted. The minimum biological capacity for N excretion in pigs, defined as total (urinary plus fecal) obligatory losses of N, is estimated to be .287g⋅kg-1BW.75⋅d-1 to support pigs at N maintenance and 1.11 g⋅kg-1BW.75⋅d-1 for pigs at maximum body N accretion. Using these estimates, the minimal biological capacity for N excretion can be calculated for pigs at various stages of growth. For example, in 60 kg pigs, minimum capacity for N excretion is estimated at .10 and .39 g/kg body weight/day in pigs in states of N maintenance and maximum body N accretion, respectively. These values are 12 and 44%, respectively, of N excretion relative to published standards (ASAE D384.1). Similarly, the N content of excreta from animals excreting N at their biological minimum was determined to be 2.57 g N/liter, or 18% of standard excreta N content (corrected for volatilization, ASAE D384.1). Based on these data, the minimum biological capacity for the excretion of N in pigs is substantially less than current estimates of N excretion and can be achieved by eliminating dietary factors that contribute to N excretion. Furthermore, dietary regimens that allow the minimum biological capacity for N excretion to be achieved are biologically capable of supporting maximum rates of body accretion (i.e., lean tissue growth) in pigs

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression

This study evaluated 1433 human immunodeficiency virus (HIV)-infected patients starting highly active antiretroviral therapy (HAART), 409 (28%) of whom had prior nucleoside experience and achieved an HIV load of <400 copies/mL by 24 weeks of therapy. Three hundred seven patients experienced virus rebound during a total of 2773.3 person-years of follow-up. There was a higher rate of virus rebound among the patients with pre-HAART nucleoside experience (relative hazard [RH], 2.86; 95% confidence interval, 2.22-3.84; P < .0001) and a decreasing rate of virus rebound with increasing duration of virus suppression (i.e., time since achieving a virus load of <400 HIV RNA copies/mL) among both the nucleoside-experienced and naive patients (P < .0001), but the difference between the groups persisted into the third year of follow-up (P = .0007). Even patients who had experienced <2 months of nucleoside therapy before beginning HAART had an increased risk of virus rebound (RH, 1.95; P = .009). It appears that only a small period of pre-HAART nucleoside therapy is sufficient to confer a disadvantage, in terms of risk of virus rebound, that persists for several years

The menopause transition in women living with HIV: current evidence and future avenues of research

As the life expectancy of people living with HIV improves as a result of antiretroviral therapy, increasing numbers of women living with HIV (WLHIV) are now reaching menopausal age. The menopause transition in WLHIV remains a relatively overlooked area in clinical HIV research. Whilst there is some evidence to suggest that WLHIV experience menopause at an earlier age and that they have more menopausal symptoms, there is no clear consensus in the literature around an impact of HIV infection on either timing or symptomatology of the menopause. Data are also conflicting on whether HIV-related factors such as HIV viral load and CD4 cell count have an impact on the menopause. Furthermore, menopausal symptoms in WLHIV are known to go under-recognised by both healthcare providers and women themselves. There is likely to be a burden of unmet health needs among WLHIV transitioning through the menopause, with significant gaps in the evidence base for their care. With this in mind, we have developed the PRIME study (Positive Transitions Through the Menopause). This mixed-methods observational study will explore, for the first time in the UK, the impact of the menopause on the health and wellbeing of 1500 ethnically diverse WLHIV. In establishing a cohort of women in their midlife and following them up longitudinally, we hope to develop a nuanced understanding of the gendered aspects of ageing and HIV, informing the provision of appropriate services for WLHIV to ensure that they are supported in maintaining optimal health and wellbeing as they get older

Prevalence of hepatitis B immunity and infection in home self-sampling HIV service users

OBJECTIVES: Although hepatitis B virus (HBV) vaccination for high-risk groups including gay, bisexual and other men who have sex with men (MSM) is recommended in the UK, data on HBV immunisation coverage are limited. This study aimed to understand the prevalence of HBV infection, susceptibility and immunity due to immunisation among a high-risk population of MSM and heterosexuals who are less likely to attend sexual health services. METHODS: Residual HIV-negative serology samples archived from a national HIV self-sampling service in 2016 were tested for HBV markers using an unlinked anonymous approach. Prevalence of HBV infection, evidence of immunisation and susceptibility were calculated and stratified by individuals' characteristics. Multinomial logistic regression was used to estimate relative risk ratios (RRRs) associated with covariates. RESULTS: Of 2172 samples tested, 1497 (68.9%) were from MSM and 657 (30.2%) were from heterosexuals. Susceptibility to HBV infection was 66.1% among MSM and 77.0% among heterosexuals. Only 29.9% of MSM and 17.4% of heterosexuals had serological evidence of immunisation. Current infection was 1.1% in heterosexuals and 0.2% in MSM. Adjusted analysis showed evidence of immunisation was lower among heterosexuals (RRR 0.66, 95% CI 0.50 to 0.86) and those with no previous HIV test (RRR 0.41, 95% CI 0.31 to 0.54), and higher in those of other white or other ethnicity. CONCLUSIONS: Among MSM and heterosexual users of a self-sampling HIV service, evidence of immunisation to HBV infection was low and susceptibility to infection was comparatively high, suggesting suboptimal delivery of HBV immunisation in sexual health services

Nuclear Effects on Bremsstrahlung Neutrino Rates of Astrophysical Interest

We calculate in this work the rates for the neutrino pair production by nucleon-nucleon bremsstrahlung taking into account the full contribution from a nuclear one-pion-exchange potential. It is shown that if the temperatures are low enough ($T \leq 20 MeV$), the integration over the nuclear part can be done for the general case, ranging from the completely degenerate (D) to the non-degenerate (ND) regime. We find that the inclusion of the full nuclear contribution enhances the neutrino pair production by $nn$ and $pp$ bremsstrahlung by a factor of about two in both the D and ND limits when compared with previous calculations. This result may be relevant for the physical conditions of interest in the semitransparent regions near the neutrinosphere in type II supernovae, cooling of neutron stars and other astrophysical situations.Comment: 11 pages, no figures, LaTex file. submitted to PR

Relationship between allometric variables and biomass in western juniper (Juniperus occidentalis)

A tenfold expansion of western juniper (Juniperus occidentalis spp. occidentalis) into the sagebrush steppe has led to the degradation of the economic and ecological potential of these landscapes. Land managers have enacted numerous methods to reduce distributions and densities of these trees. Assessment of above ground juniper biomass, expressed overall as well as in each of four fuel - size classes is useful information to land managers for several reasons. These include: enhance smoke management for prescribed burns, appraise feasibility of locating biomass cogeneration power plants, and extrapolating known nutrient and carbon concentrations contained within juniper to the landscape scale. Two sites were selected within Lake County, OR for this research. Allometric measurements including canopy area, canopy volume, age, height, basal diameter were taken from 129 trees and 56 of these were destructively sampled to obtain biomass of each tree; by size classes as well as over all. Regression statistics were utilized to find the correlation between allometric and biomass measurements. Of the allometric variables measured for this research, canopy volume, canopy area, and basal diameter were the strongest predictors of biomass found, with respective R2 values of 0.88, 0.87, 0.81. The proportion of biomass within each of the four size classes was: 34% for size class 1, 15% for size class 2, 23% for size class 3, and 28% for size class 4. Average biomass for these sites was 2,482 kg/ha for the Fort Rock site and 5,410 kg/ha for the Lakeview site. These models can be used to estimate biomass for co-generation plants, estimate nutrient pools and fuel loads, and predict changes in community biomass based on species or growth form groups

Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdon: multicentre cohort study

Objectives: To investigate whether there is evidence that an increasing proportion of HIV infected patients is starting to experience increases in viral load and decreases in CD4 cell count that are consistent with exhaustion of available treatment options. Design: Multicentre cohort study. Setting: Six large HIV treatment centres in southeast England. Participants: All individuals seen for care between 1 January 1996 and 31 December 2002. Main outcome measures: Exposure to individual antiretroviral drugs and drug classes, CD4 count, plasma HIV RNA burden. Results: Information is available on 16 593 individuals (13 378 (80.6%) male patients, 10 340 (62.3%) infected via homosexual or bisexual sex, 4426 (26.7%) infected via heterosexual sex, median age 34 years). Overall, 10 207 of the 16 593 patients (61.5%) have been exposed to any antiretroviral therapy. This proportion increased from 41.2% of patients under follow up at the end of 1996 to 71.3% of those under follow up in 2002. The median CD4 count and HIV RNA burden of patients under follow up in each year changed from 270 cells/mm3 and 4.34 log10 copies/ml in 1996 to 408 cells/mm3 and 1.89 log10 copies/ml, respectively, in 2002. By 2002, 3060 (38%) of patients who had ever been treated with antiretroviral therapy had experienced all three main classes. Of these, around one quarter had evidence of “viral load failure” with all these three classes. Patients with three class failure were more likely to have an HIV RNA burden > 2.7 log10 copies/ml and a CD4 count < 200 cells/mm3. Conclusions: The proportion of individuals with HIV infection in the United Kingdom who have been treated has increased gradually over time. A substantial proportion of these patients seem to be in danger of exhausting their options for antiretroviral treatment. New drugs with low toxicity, which are not associated with cross resistance to existing drugs, are urgently needed for such patients

The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations.

OBJECTIVES: We investigated whether age modified associations between markers of HIV progression, CD4 T lymphocyte count and HIV RNA viral load (VL), and the following markers of metabolic function: albumin, haemoglobin, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC). METHODS: A retrospective analysis of data from the United Kingdom Collaborative HIV Cohort was carried out. Analyses were limited to antiretroviral-naïve subjects to focus on the impact of HIV disease itself. A total of 16670 subjects were included in the analysis. Multilevel linear regression models assessed associations between CD4 count/VL and each of the outcomes. Statistical tests for interactions assessed whether associations differed among age groups. RESULTS: After adjustment for gender and ethnicity, there was evidence that lower CD4 count and higher VL were associated with lower TC, LDL-C, haemoglobin and albumin concentrations but higher triglyceride concentrations. Age modified associations between CD4 count and albumin (P 50 years, a 50 cells/μL lower CD4 count correlated with a 2.4 [95% confidence interval (CI) 1.7-3.0], 3.6 (95% CI 3.2-4.0) and 5.1 (95% CI 4.0-6.1) g/L lower haemoglobin concentration and a 0.09 (95% CI 0.07-0.11), 0.12 (95% CI 0.11-0.13) and 0.16 (95% CI 0.13-0.19) g/L lower albumin concentration, respectively. CONCLUSIONS: We present evidence that age modifies associations between CD4 count and plasma albumin and haemoglobin levels. A given reduction in CD4 count was associated with a greater reduction in haemoglobin and albumin concentrations among older people living with HIV. These findings increase our understanding of how the metabolic impact of HIV is influenced by age